Business Context and Reporting Period
Company: Security Devices International, Inc. (SDI), a Delaware corporation operating as a development-stage enterprise.
Reporting Period: Fiscal year ended November 30, 2010.
Business Overview: SDI specializes in developing non-lethal defense technology, specifically the Blunt Impact Projectile 40mm (BIP40) and Wireless Electric Projectile 40mm (WEP40). As of the reporting date, the company had completed design and testing for version 1.0 of both products but had not yet commenced commercial operations or generated revenue. The company is actively seeking manufacturing partnerships and joint ventures with large defense technology firms.
Key Financial Metrics
| Metric | 2010 | 2009 |
|---|---|---|
| Revenue | $0 | $0 |
| Net Loss | $(2,320,962) | $(2,974,467) |
| Accumulated Deficit (Inception to 2010) | $(16,374,650) | $(14,053,688) |
| Cash and Cash Equivalents | $247,328 | $55,431 |
| Total Assets | $314,947 | $116,527 |
| Total Liabilities | $787,641 | $691,729 |
| Working Capital Deficiency | $(501,894) | $(605,126) |
| Stock-Based Compensation Expense | $289,670 | $182,213 |
Liquidity: The company raised approximately $1.67 million in net proceeds from the issuance of common shares during the fiscal year. Cash flow from financing activities provided $1.70 million, while operating activities used $1.50 million in cash.
Material Changes vs. Prior Period
- Net Loss Reduction: Net loss decreased by approximately $653,000 compared to the prior year, primarily due to a significant reduction in Research and Product Development expenses as product design neared completion.
- Increased G&A Expenses: General and Administrative expenses increased to $1.37 million (from $941,702 in 2009). This increase was driven by a $360,000 consulting fee paid in stock to Level 4 Capital Corp., a $30,000 fee to another consultant, and higher stock-based compensation.
- Capital Structure: The company issued 10.6 million shares of common stock during the year, increasing outstanding shares from 15.2 million to 25.9 million. This included significant issuances for services and debt settlement.
- Management Changes: New management was installed in June 2010, including a new President (Gregory Sullivan) and Chief Operating Officer (Dean Thrasher), alongside two new directors with military and defense industry backgrounds.
Outlook, Risks, and Contingencies
Going Concern: The independent auditors have expressed substantial doubt about the company's ability to continue as a going concern. The company has no operating revenue, an accumulated deficit of over $16 million, and a working capital deficiency. Future success is entirely dependent on raising additional capital.
Capital Requirements: Management anticipates capital requirements of $696,000 for the twelve months ending November 30, 2011 ($120,000 for production/development and $576,000 for G&A). The filing explicitly states there are no commitments for additional capital, and without it, the company cannot fund its operations.
Risks and Contingencies:
- Regulatory: Products are classified as military/crime control items, requiring export licenses for international sales. State and local regulations may restrict sales to private citizens.
- Intellectual Property: While four patent applications are pending, there is a risk that patents may not protect proprietary technology or that competitors may develop similar products.
- Contractual Obligations: The company terminated a Memorandum of Understanding (MOU) with a research contractor. Under the terms of the terminated MOU, if the company becomes insolvent, the contractor could receive an exclusive, perpetual license to the company's technology.
Investor Verification Checklist
- Capital Sufficiency: Verify if the company has secured the $696,000 required for the upcoming fiscal year, as no commitments were disclosed in the filing.
- Going Concern Status: Assess the likelihood of bankruptcy or forced liquidation given the $501,894 working capital deficiency and lack of revenue.
- Technology Licensing Risk: Confirm the current status of negotiations with the former research contractor to ensure the company retains exclusive rights to its IP in the event of financial distress.
- Dilution: Review the impact of the 10.6 million shares issued in 2010 and the 1.45 million outstanding options/1.29 million warrants on future equity value.
- Management Execution: Evaluate the progress of the proposed joint ventures with large defense technology companies mentioned in the MD&A.